Endocrine🍬 Flashcards

1
Q

Diagnostic test for Addisons disease

A

Short synacthen test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type of parathyroidism caused in CKD?

A

Secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment for Grave’s in first trimester

A

Propylthiouracil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Long term management of Addison’s

A

Cortisol and aldosterone replacement: hydrocortisone and fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypocalcaemia ECG change

A

Prolonged QT interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of secondary hyperparathyroidism in CKD

A

Vitamin D analogues and phosphate binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HLA associated to T1DM

A

HLA-DR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

First line anti thyroid medication

A

Carbimazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Serious complication of rapid correction of hyponatraemia

A

myelinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why should hypernatraemia be corrected slowly?

A

Avoid cerebral oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HbA1c level for diagnosis of diabetes

A

> 48

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fasting plasma glucose for diabetes diagnosis

A

> 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Long term treatment for T1DM

A

Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diabetes drug with cardiovascular and renal benefits

A

Empagliflozin (SGLT 2 inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HLA genotype associated to T1DM

A

HLA DR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd line diabetes medication after metformin in patients with CV risk or CKD

A

SGLT 2 inhibitor e.g. empagliflozin

17
Q

2nd line T2DM medication in patients with no contraindications

A

DPP4 inhibitor - Sitagliptin

OR sulfonylurea - Gliclazide

18
Q

Initial fixed-rate insulin infusion dose in DKA

A

0.1 units/kg/hour

19
Q

Key indicator test result for T1DM

A

Low serum C peptide

20
Q

First line treatment for De Quervain’s thyroiditis

A

NSAIDs